Pure Biologics

Pure Biologics EBIT per Share

The EBIT per Share of Pure Biologics (PUR.WA) as of Nov 12, 2026 is -0.78 PLN. In the previous year, EBIT per Share was -3.30 PLN — a change of -76.51% (higher).

EBIT per Share

-0.78PLN

YoY

-76.51%

Last updated:

EBIT per Share of Pure Biologics is 2025 -0.78 PLN. EBIT per Share of Pure Biologics was 2024 -3.30 PLN. It decreases by -76.51% higher compared to the previous year.

The Pure Biologics EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.54 PLN
Jan 1, 2019
-2.64 PLN
Jan 1, 2020
-5.45 PLN
Jan 1, 2021
-4.65 PLN
Jan 1, 2022
-10.93 PLN
Jan 1, 2023
-9.65 PLN
Jan 1, 2024
-3.30 PLN
Jan 1, 2025
-0.78 PLN
The Pure Biologics EBIT per Share history
YEAREBIT per ShareYoY
-0.78PLN-76.51%
-3.30PLN-65.78%
-9.65PLN-11.72%
-10.93PLN+134.96%
-4.65PLN-14.66%
-5.45PLN+106.39%
-2.64PLN+390.54%
-0.54PLN+63.37%
-0.33PLN+808.31%
-0.04PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

EBIT per Share of Pure Biologics is -0.78 PLN in 2025.

EBIT per Share of Pure Biologics changed from -3.30 PLN to -0.78 PLN, representing a -76.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Pure Biologics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pure Biologics